1-3 of 3
David A. Sweet
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Study Comparing Dosing Regimens and Efficacy of Subcutaneous to Intravenous Azacitidine (AZA) for the Treatment of Myelodysplastic Syndromes (MDS).

Mikkael A. Sekeres, MD, MS, Jaroslaw P. Maciejewski, MD, PhD, David W. Donley, David L. Grinblatt, MD, Mohit Narang, MD, James M. Malone, III, MD, Rami S. Komrokji, MD, Alan F List, MD, Julie G. Baker, David A. Sweet, CMR, Kristen A. Sullivan
Journal: Blood
Blood (2009) 114 (22): 3797.
https://doi.org/10.1182/blood.V114.22.3797.3797
Published: 2009
Journal Articles

Transfusion Independence in Patients with Hematologic Disorders Receiving Azacitidine Who Are Enrolled in AVIDA, a Longitudinal Patient Registry

David L. Grinblatt, MD, Mohit Narang, MD, James M. Malone, III, MD, David A. Sweet, Tim S. Dunne, Kristen A. Sullivan
Journal: Blood
Blood (2008) 112 (11): 2683.
https://doi.org/10.1182/blood.V112.11.2683.2683
Published: 2008
Journal Articles

Treatment of Patients with Low-Risk Myelodysplastic Syndromes Receiving Azacitidine Who Are Enrolled in AVIDA, a Longitudinal Patient Registry.

David L. Grinblatt, MD, Mohit Narang, MD, James M. Malone, III, MD, David A. Sweet, Tim S. Dunne, Kristen A. Sullivan
Journal: Blood
Blood (2008) 112 (11): 1646.
https://doi.org/10.1182/blood.V112.11.1646.1646
Published: 2008